Literature DB >> 28980204

Mechanistic Fluid Transport Model to Estimate Gastrointestinal Fluid Volume and Its Dynamic Change Over Time.

Alex Yu1, Trachette Jackson2, Yasuhiro Tsume1, Mark Koenigsknecht1, Jeffrey Wysocki3, Luca Marciani4, Gordon L Amidon1, Ann Frances1, Jason R Baker3, William Hasler3, Bo Wen1, Amit Pai5, Duxin Sun6,7,8.   

Abstract

Gastrointestinal (GI) fluid volume and its dynamic change are integral to study drug disintegration, dissolution, transit, and absorption. However, key questions regarding the local volume and its absorption, secretion, and transit remain unanswered. The dynamic fluid compartment absorption and transit (DFCAT) model is proposed to estimate in vivo GI volume and GI fluid transport based on magnetic resonance imaging (MRI) quantified fluid volume. The model was validated using GI local concentration of phenol red in human GI tract, which was directly measured by human GI intubation study after oral dosing of non-absorbable phenol red. The measured local GI concentration of phenol red ranged from 0.05 to 168 μg/mL (stomach), to 563 μg/mL (duodenum), to 202 μg/mL (proximal jejunum), and to 478 μg/mL (distal jejunum). The DFCAT model characterized observed MRI fluid volume and its dynamic changes from 275 to 46.5 mL in stomach (from 0 to 30 min) with mucus layer volume of 40 mL. The volumes of the 30 small intestine compartments were characterized by a max of 14.98 mL to a min of 0.26 mL (0-120 min) and a mucus layer volume of 5 mL per compartment. Regional fluid volumes over 0 to 120 min ranged from 5.6 to 20.38 mL in the proximal small intestine, 36.4 to 44.08 mL in distal small intestine, and from 42 to 64.46 mL in total small intestine. The DFCAT model can be applied to predict drug dissolution and absorption in the human GI tract with future improvements.

Entities:  

Keywords:  compartmental absorption and transit; dynamic; gastrointestinal tract; mechanistic model; oral absorption

Mesh:

Substances:

Year:  2017        PMID: 28980204     DOI: 10.1208/s12248-017-0145-x

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  22 in total

Review 1.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability.

Authors:  B Agoram; W S Woltosz; M B Bolger
Journal:  Adv Drug Deliv Rev       Date:  2001-10-01       Impact factor: 15.470

Review 2.  The physiology of gastric emptying.

Authors:  Per M Hellström; Per Grybäck; Hans Jacobsson
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2006-09

3.  Normal small bowel wall characteristics on MR enterography.

Authors:  Carmel G Cronin; Eithne Delappe; Derek G Lohan; Clare Roche; Joseph M Murphy
Journal:  Eur J Radiol       Date:  2009-06-04       Impact factor: 3.528

Review 4.  Mechanistic approaches to predicting oral drug absorption.

Authors:  Weili Huang; Sau Lawrence Lee; Lawrence X Yu
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

Review 5.  PBPK models for the prediction of in vivo performance of oral dosage forms.

Authors:  Edmund S Kostewicz; Leon Aarons; Martin Bergstrand; Michael B Bolger; Aleksandra Galetin; Oliver Hatley; Masoud Jamei; Richard Lloyd; Xavier Pepin; Amin Rostami-Hodjegan; Erik Sjögren; Christer Tannergren; David B Turner; Christian Wagner; Werner Weitschies; Jennifer Dressman
Journal:  Eur J Pharm Sci       Date:  2013-09-21       Impact factor: 4.384

Review 6.  Physiological parameters for oral delivery and in vitro testing.

Authors:  Deanna M Mudie; Gordon L Amidon; Gregory E Amidon
Journal:  Mol Pharm       Date:  2010-09-07       Impact factor: 4.939

Review 7.  Modeling the fluid dynamics in a human stomach to gain insight of food digestion.

Authors:  M J Ferrua; R P Singh
Journal:  J Food Sci       Date:  2010-09       Impact factor: 3.167

8.  Anatomical study of the length of the human intestine.

Authors:  G Hounnou; C Destrieux; J Desmé; P Bertrand; S Velut
Journal:  Surg Radiol Anat       Date:  2002-10-10       Impact factor: 1.246

Review 9.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system.

Authors:  Thaher Pelaseyed; Joakim H Bergström; Jenny K Gustafsson; Anna Ermund; George M H Birchenough; André Schütte; Sjoerd van der Post; Frida Svensson; Ana M Rodríguez-Piñeiro; Elisabeth E L Nyström; Catharina Wising; Malin E V Johansson; Gunnar C Hansson
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

10.  Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.

Authors:  Malin E V Johansson; Jenny K Gustafsson; Jessica Holmén-Larsson; Karolina S Jabbar; Lijun Xia; Hua Xu; Fayez K Ghishan; Frederic A Carvalho; Andrew T Gewirtz; Henrik Sjövall; Gunnar C Hansson
Journal:  Gut       Date:  2013-02-20       Impact factor: 23.059

View more
  6 in total

Review 1.  Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies.

Authors:  Neil A Miller; Micaela B Reddy; Aki T Heikkinen; Viera Lukacova; Neil Parrott
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

2.  Formulation and Evaluation of SNEDDS Loaded with Original Lipophenol for the Oral Route to Prevent Dry AMD and Stragardt's Disease.

Authors:  Maxime Vincent; Laurianne Simon; Philippe Brabet; Philippe Legrand; Christophe Dorandeu; Josephine Lai Kee Him; Thierry Durand; Céline Crauste; Sylvie Begu
Journal:  Pharmaceutics       Date:  2022-05-10       Impact factor: 6.525

3.  Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.

Authors:  Bart Hens; Arjang Talattof; Paulo Paixão; Marival Bermejo; Yasuhiro Tsume; Raimar Löbenberg; Gordon L Amidon
Journal:  AAPS J       Date:  2018-03-29       Impact factor: 4.009

4.  Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution.

Authors:  Alex Yu; Mark J Koenigsknecht; Bart Hens; Jason R Baker; Bo Wen; Trachette L Jackson; Manjunath P Pai; William Hasler; Gordon L Amidon; Duxin Sun
Journal:  AAPS J       Date:  2019-11-11       Impact factor: 4.009

Review 5.  Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.

Authors:  Bart Hens; Patrick D Sinko; Nicholas Job; Meagan Dean; Jozef Al-Gousous; Niloufar Salehi; Robert M Ziff; Yasuhiro Tsume; Marival Bermejo; Paulo Paixão; James G Brasseur; Alex Yu; Arjang Talattof; Gail Benninghoff; Peter Langguth; Hans Lennernäs; William L Hasler; Luca Marciani; Joseph Dickens; Kerby Shedden; Duxin Sun; Gregory E Amidon; Gordon L Amidon
Journal:  Int J Pharm       Date:  2018-06-23       Impact factor: 5.875

6.  A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP.

Authors:  Marival Bermejo; Bart Hens; Joseph Dickens; Deanna Mudie; Paulo Paixão; Yasuhiro Tsume; Kerby Shedden; Gordon L Amidon
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.